Genomics

Dataset Information

0

MDA-MB-468 and SUM149PT cell lines treated with AKTi (ipatasertib) and EZH2i (tazemetostat)

ABSTRACT: MDA-MB-468 and SUM149PT cell lines treated with AKTi (ipatasertib) and EZH2i (tazemetostat)

PROVIDER: PRJNA847247 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR19589052_1.fastq.gz Fastqsanger.gz
SRR19589052_2.fastq.gz Fastqsanger.gz
SRR19589053_1.fastq.gz Fastqsanger.gz
SRR19589053_2.fastq.gz Fastqsanger.gz
SRR19589054_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 48

Similar Datasets

Transcriptomics MDA-MB-468 cell line treated with AKTi (ipatasertib) and EZH2i (tazemetostat)
2024-01-01 | GSE205729 | GEO
Transcriptomics SUM149PT cell line treated with AKTi (ipatasertib) and EZH2i (tazemetostat)
2024-01-01 | GSE205730 | GEO
Genomics MDA-MB-468 cell line treated with AKTi (ipatasertib) and EZH2i (tazemetostat)
| PRJNA847253 | ENA
Genomics SUM149PT cell line treated with AKTi (ipatasertib) and EZH2i (tazemetostat)
| PRJNA847252 | ENA
Genomics MDA-MB-468 cells treated with docetaxel or EZH2i+AKTi
| PRJNA1055096 | ENA
Genomics MDA-MB-468 cells treated with docetaxel or EZH2i+AKTi I
| PRJNA1054653 | ENA
Genomics MDA-MB-468 cells treated with docetaxel or EZH2i+AKTi II
| PRJNA1055097 | ENA
Genomics ATACseq of TNBC cell lines treated with EZH2i (tazemetostat) and/or AKTi (ipatasertib)
| PRJNA1060317 | ENA
Transcriptomics MDA-MB-468 and SUM149PT cell lines treated with AKTi (ipatasertib) and EZH2i (tazemetostat)
2024-01-01 | GSE205731 | GEO
Transcriptomics MDA-MB-468 cells treated with docetaxel or EZH2i+AKTi
2024-07-08 | GSE251710 | GEO